To compare the pharmacokinetics after administration of different formulation of CJ-12420
The purpose of this study is to compare the pharmacokinetics after a single dose administration of CJ-12420 formulation 1 and formulation 2.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
12
CJ-12420 formulation 2
CJ-12420 formulation 1
Chonbuk National University Hospital
Jeonju, South Korea
Assessment of the AUClast
Time frame: Up to 48 hours
Assessment of the AUCinf
Time frame: Up to 48 hours
Tmax
Time frame: Up to 48 hours
t1/2
Time frame: Up to 48 hours
Vd/F
Time frame: Up to 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.